Oppose 57% Cut to Congressionally Directed Medical Research Programs | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Oppose 57% Cut to Congressionally Directed Medical Research Programs

Original Publication Date: 
Monday, March 10, 2025
Article Source: 
Community Impact

Oppose 57% Cut to Congressionally Directed Medical Research Programs 

Take Action Before House Vote 

Oppose 57% Cut to Congressionally Directed Medical Research Programs
Tell your Members of Congress to Vote NO on The Full-Year Continuing Appropriations and Extensions Act, 2025

As early as this Tuesday, the House will be voting on a continuing resolution to fund government programs through the end of fiscal year 2025 (FY25).
This legislation cuts FY25 funding for the Department of Defense’s Congressionally Directed Medical Research Program (CDMRP) from $1.509 billion to $650 million – a 57 percent cut from the FY24 enacted level.

CDMRP funding is responsible for ongoing research into the chronic and life-threatening diseases that can affect Armed Forces personnel, both active-duty and veterans. This research includes significant funding for Aplastic Anemia, Myelodysplastic Syndromes (MDS), Paroxysmal Nocturnal Hemoglobinuria, and other Bone Marrow Failure Diseases.

A vote for The Full-Year Continuing Appropriations and Extensions Act, 2025, is a vote to cut off federally funded medical research.

Read about the CDMRP Bone Marrow Failure Disease goals here: https://cdmrp.health.mil/bmfrp/default